Profound Medical Corp.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
PROF$7.68+4.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW****S
| | | | | |
|---|---|---|---|---|
| · · Nine Months Ended September 30, | ||||
| | 2025 | 2024 | ||
| | | $ | | $ |
| Cash flows from operating activities | ||||
| Net loss for the period | (34,395) | | (22,869) | |
| Adjustments to reconcile net loss to net cash provided by operating activities: | | | | |
| Depreciation of property and equipment (note 5) | 311 | | 547 | |
| Amortization of intangible assets (note 6) | 140 | | 151 | |
| Non-cash lease expense adjustment | (28) | | (34) | |
| Share-based compensation (note 10) | 4,109 | | 2,139 | |
| Interest and accretion expense | 58 | | 467 | |
| Change in amortized cost of trade and other receivables | — | | (238) | |
| Changes in operating assets and liabilities: | | | | |
| Trade and other receivables (note 3) | (908) | | 781 | |
| Inventory (note 4) | (2,593) | | 176 | |
| Prepaid expenses and deposits | 1,158 | | 1,056 | |
| Accounts payable, accrued expenses and other liabilities (note 7) | 338 | | 169 | |
| Deferred revenue | 101 | | 67 | |
| Income taxes payable | 58 | | 14 | |
| Deferred tax liabilities | 10 | | — | |
| Net cash used in operating activities | (31,641) | | (17,574) | |
| | | | | |
| Cash flows from financing activities | | | | |
| Repayments of long-term debt (note 8) | | (290) | | (1,819) |
| Issuance of commons shares (note 10) | | — | | 22,938 |
| Payments of financing costs (note 10) | | — | | (1,859) |
| Proceeds from the exercise of stock options (note 10) | — | 1 | ||
| Net cash provided by (used in) financing activities | | (290) | | 19,261 |
| | | | | |
| Net increase (decrease) in cash | | (31,931) | | 1,687 |
| Effect of exchange rate changes on cash | | 1,845 | | (777) |
| Cash, beginning of period | | 54,912 | | 26,213 |
| Cash, end of period | | 24,826 | | 27,123 |
| | | | | |
| Supplemental cash flow information: | | | | |
| Interest paid, included in operating activities | | 251 | | 440 |
| Income taxes paid, included in operating activities | | 100 | | 212 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.